Pedersen M M, Schmitz A, Pedersen E B, Danielsen H, Christiansen J S
Second University Clinic of Internal Medicine, Aarhus Kommunehospital, Denmark.
Diabet Med. 1988 Sep;5(6):562-9. doi: 10.1111/j.1464-5491.1988.tb01052.x.
Glomerular filtration rate (GFR) (thalamate clearance), renal plasma flow (RPF) (hippuran clearance), and urinary albumin excretion rate (AER) were measured in 10 normoalbuminuric, normotensive insulin-dependent diabetic patients and 8 normal subjects before and during acute angiotensin converting enzyme (ACE) inhibition by means of enalapril (10 mg IV). The effect of placebo versus enalapril (30 mg day-1) was also studied for 3-month treatment periods in the insulin-dependent diabetic patients. Acute ACE-inhibition caused a decline in filtration fraction (FF) from 0.259 +/- 0.011 (+/- SE) to 0.237 +/- 0.013 (2p less than 0.01) in the diabetic patients, and from 0.210 +/- 0.010 to 0.188 +/- 0.006 (2p less than 0.02) in the normal subjects. Mean arterial blood pressure was lowered from 90 +/- 1 to 84 +/- 2 mmHg (2p less than 0.01) and from 91 +/- 1 to 86 +/- 2 mmHg (2p less than 0.05). No significant change in blood glucose, AER or fractional albumin excretion (theta Alb) was seen in either group. After 3 months of enalapril treatment FF was decreased from 0.253 +/- 0.011 to 0.235 +/- 0.011 (2p less than 0.05), AER from 5.6 x/ divided by 1.7 to 4.3 x/divided by 1.6 micrograms min-1 (2p less than 0.01) and theta Alb from 1.22 +/- 0.22 x 10(-6) to 0.92 +/- 0.12 x 10(-6) (2p less than 0.02). The decline in total renal resistance was not significant (0.175 +/- 0.013 to 0.165 +/- 0.012 mmHg ml-1 min-1) and significant changes in GFR, RPF, mean arterial pressure or HbA1c were not observed.(ABSTRACT TRUNCATED AT 250 WORDS)
在10例正常白蛋白尿、血压正常的胰岛素依赖型糖尿病患者和8名正常受试者中,于静脉注射依那普利(10mg)急性抑制血管紧张素转换酶(ACE)之前及期间,测量了肾小球滤过率(GFR)(马尿酸盐清除率)、肾血浆流量(RPF)(碘马尿酸清除率)及尿白蛋白排泄率(AER)。还在胰岛素依赖型糖尿病患者中研究了为期3个月的安慰剂与依那普利(30mg/日)治疗的效果。急性ACE抑制使糖尿病患者的滤过分数(FF)从0.259±0.011(±标准误)降至0.237±0.013(P<0.01),正常受试者的FF从0.210±0.010降至0.188±0.006(P<0.02)。平均动脉血压从90±1mmHg降至84±2mmHg(P<0.01),从91±1mmHg降至86±2mmHg(P<0.05)。两组的血糖、AER或白蛋白排泄分数(θAlb)均无显著变化。依那普利治疗3个月后,FF从0.253±0.011降至0.235±0.011(P<0.05),AER从5.6×/÷1.7降至4.3×/÷1.6μg/min(P<0.01),θAlb从1.22±0.22×10⁻⁶降至0.92±0.12×10⁻⁶(P<0.02)。总肾阻力的下降不显著(从0.175±0.013降至0.165±0.012mmHg·ml⁻¹·min⁻¹),且未观察到GFR、RPF、平均动脉血压或糖化血红蛋白(HbA1c)有显著变化。(摘要截短于250字)